Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

Home
603351.SS
Financials

29.09 (CNY) • At close June 10, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1
Revenue Numbers are in millions	349.725	296.389	312.207	356.158	329.832	327.16	305.709	276.525	246.445	260.035	262.865	297.524	290.586	278.111	279.405	257.359	227.431	224.441	179.355	176.861	155.406	220.03	222.941	225.049	212.736	201.543	192.455	215.647	191.806	178.984	184.137	165.495	165.495
Cost of Revenue Numbers are in millions	258.645	188.46	231.76	271.657	243.995	236.069	227.964	203.137	171.866	206.696	192.447	204.073	204.746	222.558	192.793	176.182	156.388	165.426	117.901	108.332	92.575	144.623	149.427	148.51	134.969	139.74	134.979	146.931	130.492	118.229	125.399	107.951	107.951
Gross Profit Numbers are in millions	91.081	107.929	80.446	84.501	85.837	91.09	77.745	73.388	74.58	53.339	70.418	93.451	85.84	55.553	86.612	81.177	71.043	59.015	61.454	68.529	62.831	75.408	73.514	76.539	77.766	61.803	57.475	68.716	61.314	60.755	58.738	57.544	57.544
Gross Profit Ratio Numbers are in millions	0.26	0.364	0.258	0.237	0.26	0.278	0.254	0.265	0.303	0.205	0.268	0.314	0.295	0.2	0.31	0.315	0.312	0.263	0.343	0.387	0.404	0.343	0.33	0.34	0.366	0.307	0.299	0.319	0.32	0.339	0.319	0.348	0.348
Reseach & Development Expenses Numbers are in millions	18.199	23.87	15.859	13.183	15.769	15.08	15.159	12.461	12.944	16.875	12.535	13.609	10.848	6.533	14.652	10.776	9.498	11.39	8.531	8.856	7.81	9.755	9.298	7.094	6.766	6.281	5.678	6.982	6.193	23.277	0	4.829	4.829
General & Administrative Expenses Numbers are in millions	22.881	-32.301	54.59	-6.106	22.794	-30.01	56.4	-3.258	23.072	-51.771	74.429	-4.246	35.286	-38.166	65.634	-12.768	21.064	-47.363	23.491	-9.278	17.143	-32.724	17.239	-7.573	15.776	-48.385	22.123	-3.248	13.322	-39.293	22.93	13.583	13.583
Selling & Marketing Expenses Numbers are in millions	3.065	-4.805	7.607	3.905	2.883	4.153	3.185	3.589	1.908	2.275	3.432	3.436	3.042	5.682	2.877	3.179	2.396	-11.722	7.99	8.16	6.038	14.86	8.291	8.83	8.008	9.662	7.622	7.686	6.593	7.523	7.093	6.845	6.845
SG&A Numbers are in millions	25.945	-37.107	62.197	25.403	25.676	-25.857	59.585	0.33	24.98	-49.495	77.861	-0.811	38.328	-32.484	68.511	-9.589	23.46	-59.085	31.481	-1.117	23.181	-17.864	25.53	1.257	23.784	-38.723	29.745	4.438	19.915	-31.77	30.023	20.427	20.427
Other Expenses Numbers are in millions	3.917	77.714	-31.804	-3.848	-0.012	-0.184	-0.02	-0.094	1.029	60.228	-40.376	41.21	1.21	-0.588	-0.232	-0.109	-0.092	0.249	-0.081	-0.051	-0.748	-1.617	-0.242	-1.175	-0.01	3.74	-0.303	-0.024	-0.003	-0.11	-0.036	0	0
Operating Expenses Numbers are in millions	48.061	64.477	46.253	42.434	42.339	48.453	46.618	44.25	38.953	27.608	50.02	54.008	50.386	43.876	49.233	38.259	34.099	26.817	41.495	40.06	29.031	48.435	36.074	31.025	30.654	32.266	29.951	27.325	25.856	31.126	30.708	21.5	21.5
Operating Income Numbers are in millions	43.019	43.452	34.194	42.067	40.841	37.828	27.348	24.962	31.637	25.087	18.92	37.133	32.09	6.96	36.601	41.398	34.798	30.028	20.259	30.725	37.9	26.643	39.968	45.826	44.726	28.493	27.298	39.819	32.031	28.294	26.695	35.928	35.928
Operating Income Ratio Numbers are in millions	0.123	0.147	0.11	0.118	0.124	0.116	0.089	0.09	0.128	0.096	0.072	0.125	0.11	0.025	0.131	0.161	0.153	0.134	0.113	0.174	0.244	0.121	0.179	0.204	0.21	0.141	0.142	0.185	0.167	0.158	0.145	0.217	0.217
Total Other Income Expenses Net Numbers are in millions	-0.07	-0.052	-0.094	11.736	-0.012	-0.184	-0.02	-0.094	-0.037	-0.261	-0.036	-0.037	-0.046	-0.588	-0.232	-0.109	-0.092	0.249	-0.081	-0.051	-0.748	-1.617	-0.242	-1.175	-0.01	3.74	-0.303	-0.024	-0.003	-0.11	-0.036	-0.511	-0.511
Income Before Tax Numbers are in millions	42.95	43.4	34.099	53.802	40.829	37.645	27.328	24.868	31.601	24.827	18.884	37.096	32.044	6.372	36.368	41.289	34.706	30.277	20.178	30.674	37.152	25.026	39.726	44.651	44.716	32.233	26.995	39.794	32.028	28.184	26.66	35.418	35.418
Income Before Tax Ratio Numbers are in millions	0.123	0.146	0.109	0.151	0.124	0.115	0.089	0.09	0.128	0.095	0.072	0.125	0.11	0.023	0.13	0.16	0.153	0.135	0.113	0.173	0.239	0.114	0.178	0.198	0.21	0.16	0.14	0.185	0.167	0.157	0.145	0.214	0.214
Income Tax Expense Numbers are in millions	7.184	9.226	0.781	9.606	7.313	4.51	3.319	-1.467	5.965	7.643	1.442	4.052	5.281	-10.392	9.482	11	8.496	5.433	2.025	5.411	4.966	7.294	5.855	6.313	6.549	4.52	4.046	5.663	5.006	3.381	4.519	5.172	5.172
Net Income Numbers are in millions	36.588	33.525	34.002	44.292	34.604	33.928	24.885	27.076	26.311	16.477	17.789	33.233	27.53	17.529	27.343	30.289	26.209	24.844	18.153	25.263	32.187	17.732	33.871	38.338	38.167	27.713	22.948	34.131	27.022	24.803	22.136	30.247	30.247
Net Income Ratio Numbers are in millions	0.105	0.113	0.109	0.124	0.105	0.104	0.081	0.098	0.107	0.063	0.068	0.112	0.095	0.063	0.098	0.118	0.115	0.111	0.101	0.143	0.207	0.081	0.152	0.17	0.179	0.138	0.119	0.158	0.141	0.139	0.12	0.183	0.183
EPS Numbers are in millions	0.27	0.247	0.25	0.34	0.26	0.44	0.19	0.2	0.2	0.12	0.14	0.25	0.21	0.16	0.21	0.23	0.2	0.19	0.14	0.19	0.24	0.13	0.26	0.32	0.31	0.28	0.24	0.35	0.28	0.25	0.22	0.31	0.31
EPS Diluted Numbers are in millions	0.27	0.247	0.25	0.34	0.26	0.44	0.19	0.2	0.2	0.12	0.14	0.25	0.21	0.16	0.21	0.23	0.2	0.19	0.14	0.19	0.24	0.13	0.26	0.32	0.31	0.28	0.24	0.35	0.28	0.25	0.22	0.31	0.31
EBITDA Numbers are in millions	45.871	46.689	37.033	84.109	60.135	58.796	48.743	47.609	53.233	47.885	41.766	56.501	50.729	21.266	51.051	52.215	45.187	40.252	30.387	40.863	47.14	35.118	49.811	54.418	53.096	38.874	34.733	41.141	34.311	30.728	28.03	-0.51	-0.51
EBITDA Ratio Numbers are in millions	0.131	0.158	0.119	0.236	0.182	0.18	0.159	0.172	0.216	0.184	0.159	0.19	0.175	0.076	0.183	0.203	0.199	0.179	0.169	0.231	0.303	0.16	0.223	0.242	0.25	0.193	0.18	0.191	0.179	0.172	0.152	-0.003	-0.003

Nanjing Well Pharmaceutical Group Co.,Ltd.

SSE:603351.SS Add to watchlist

SSE:603351.SS